DUBLIN, Jan. 28, 2019 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of
Continue reading »![](https://mypharmacynews.com/wp-content/uploads/sites/11/2018/04/EjwKwSWciRLusWfuPtkX-880x599.jpg)
mypharmacynews.com
Home ยป
DUBLIN, Jan. 28, 2019 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of
Continue reading »